GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bcworldpharm Co Ltd (XKRX:200780) » Definitions » Gross-Profit-to-Asset %

Bcworldpharm Co (XKRX:200780) Gross-Profit-to-Asset % : 14.97% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bcworldpharm Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Bcworldpharm Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was ₩27,270 Mil. Bcworldpharm Co's average Total Assets over the quarter that ended in Mar. 2024 was ₩182,221 Mil. Therefore, Bcworldpharm Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 14.97%.


Bcworldpharm Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Bcworldpharm Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bcworldpharm Co Gross-Profit-to-Asset % Chart

Bcworldpharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.11 12.09 11.28 15.12 17.41

Bcworldpharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.94 19.32 14.50 17.61 14.97

Competitive Comparison of Bcworldpharm Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - General subindustry, Bcworldpharm Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bcworldpharm Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bcworldpharm Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Bcworldpharm Co's Gross-Profit-to-Asset % falls into.



Bcworldpharm Co Gross-Profit-to-Asset % Calculation

Bcworldpharm Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=31963.141/( (183050.719+184110.789)/ 2 )
=31963.141/183580.754
=17.41 %

Bcworldpharm Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=27270.004/( (184110.789+180331.223)/ 2 )
=27270.004/182221.006
=14.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Bcworldpharm Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Bcworldpharm Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bcworldpharm Co (XKRX:200780) Business Description

Traded in Other Exchanges
N/A
Address
78, Gaepo-ro 22-gil, Gangnam-gu, Seoul, KOR
Bcworldpharm Co Ltd is a pharmaceutical company. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics. The products are offered under ALIMA Inj, AROXOL Tab, ASCORBIC Inj and BC CITICOLINE Inj brands.

Bcworldpharm Co (XKRX:200780) Headlines

No Headlines